News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GRAY WILLIAM GARRETT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/04/2023 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 03/03/2023 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 1,914 shares
@ $4.66, valued at
$8.9k
Granted 7,500 shares
@ $0
Sold 3,591 shares
@ $5, valued at
$18k
|
|
| 02/03/2023 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 3,154 shares
@ $4.79, valued at
$15.1k
|
|
| 01/12/2023 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 1,858 shares
@ $6.749, valued at
$12.5k
|
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 137,000 shares
@ $0
Sold 37,063 shares
@ $2.508, valued at
$93k
|
|
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 2,406 shares
@ $2.7899, valued at
$6.7k
|
|
| 05/22/2020 |
4
| GRAY WILLIAM GARRETT (See Remarks) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 17,104 shares
@ $1.995, valued at
$34.1k
|
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| GRAY WILLIAM GARRETT (See Remarks) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 90,000 shares
@ $0 |
|
| 02/01/2018 |
4
| GRAY WILLIAM GARRETT (See Remarks) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 12/22/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|